Status:

UNKNOWN

Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy

Lead Sponsor:

Chen Xiangmei

Collaborating Sponsors:

Jiangsu Suzhong Pharmaceutical Group Co., Ltd.

Conditions:

IgA Nephropathy

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

-IgA nephropathy is the most common primary glomerular disease in China, Huangkui Capsule is a single medicament of traditional Chinese medicine consists of Abelmoschus manihot and has been widely use...

Detailed Description

The test has not been completed .

Eligibility Criteria

Inclusion

  • Clinical diagnosed as chronic nephritic syndrome
  • IgA nephropathy diagnosed by kidney biopsy
  • Aged from 18 to 65 years,male or female
  • Blood pressure of ≤140/90mmHg
  • Estimated Glomerular Filtration Rate (eGFR)≥45ml/min/1.73 m2
  • 24-hour proteinuria ranged between 0.5g-3.0g
  • Obtaining the signed informed consent from patients

Exclusion

  • Secondary IgA nephropathy
  • Be allergic to Huangkui Capsule or Losartan potassium tablet
  • Taken Huangkui Capsule or ACEI or ARB in last 6 weeks
  • Taken the glucocorticoids, immunosuppressants or common threewingnut root and such as drugs with immunosuppressive actions in the last 12 months
  • Blood pressure \<90/60mmHg
  • Serum potassium level \> 5.5mmol / L
  • Serum albumin level \<30g / L
  • Lactation, pregnancy or plans pregnancy during the study period
  • Unilateral or bilateral renal artery stenosis
  • Combined with severe primary diseases of heart, brain, liver and hematopoietic system and so on, or other serious diseases which can affect the patient's life
  • Participating in another clinical study in the same period

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2017

Estimated Enrollment :

1600 Patients enrolled

Trial Details

Trial ID

NCT02231125

Start Date

September 1 2014

End Date

December 1 2017

Last Update

July 6 2016

Active Locations (88)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 22 (88 locations)

1

The First Hospital of Anhui Medical University

Hefei, Anhui, China, 230000

2

The Second Hospital of Anhui Medical University

Hefei, Anhui, China, 230000

3

Beijing Chao-yang Hospital

Beijing, Beijing Municipality, China, 100000

4

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China, 100000

Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy | DecenTrialz